{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:39:33Z","timestamp":1787495973913,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.seizure.2021.07.019","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T05:54:08Z","timestamp":1626760448000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Associations of overweight and obesity with drug-resistant epilepsy"],"prefix":"10.1016","volume":"92","author":[{"given":"Man","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.07.019_bib0001","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","article-title":"Estimation of the burden of active and lifetime epilepsy: a meta-analytic approach","volume":"51","author":"Ngugi","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"L\u00f6scher","year":"2020","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.seizure.2021.07.019_bib0003","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1212\/WNL.0b013e3181ab2b11","article-title":"Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy","volume":"73","author":"Daniels","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.019_bib0004","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.yebeh.2013.05.012","article-title":"Obesity in adults with epilepsy","volume":"28","author":"Janousek","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.07.019_bib0005","doi-asserted-by":"crossref","first-page":"iv65","DOI":"10.1093\/ndt\/gft242","article-title":"Obesity as an effect modifier of the risk of death in chronic kidney disease","volume":"28","author":"Kramer","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.seizure.2021.07.019_bib0006","first-page":"323","article-title":"Neck circumference and central obesity are independent predictors of coronary artery disease in patients undergoing coronary angiography","volume":"2","author":"Zen","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.seizure.2021.07.019_bib0007","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1212\/WNL.0000000000002611","article-title":"Obesity and overweight as CAE comorbidities and differential drug response modifiers","volume":"86","author":"Arya","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.07.019_bib0008","doi-asserted-by":"crossref","first-page":"14361","DOI":"10.1523\/JNEUROSCI.3171-11.2011","article-title":"Metabolic dysfunction associated with adiponectin deficiency enhances kainic acid-induced seizure severity","volume":"31","author":"Lee","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.seizure.2021.07.019_bib0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12868-015-0202-2","article-title":"High-fat diet-induced obesity exacerbates kainic acid-induced hippocampal cell death","volume":"16","author":"Kang","year":"2015","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.seizure.2021.07.019_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2007.12.051","article-title":"Increased severity of pentylenetetrazol-induced seizures in leptin-deficient ob\/ob mice","volume":"433","author":"Erbayat-Altay","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2021.07.019_bib0011","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1172\/JCI33009","article-title":"Leptin inhibits 4-aminopyridine- and pentylenetetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents","volume":"118","author":"Xu","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.seizure.2021.07.019_bib0012","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0013","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0014","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug-resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.seizure.2021.07.019_bib0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1539\/joh.45.335","article-title":"The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers","volume":"45","author":"Anuurad","year":"2003","journal-title":"J Occup Health"},{"key":"10.1016\/j.seizure.2021.07.019_bib0016","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.2147\/DMSO.S274110","article-title":"Forecasting the Populations of Overweight and Obese Chinese Adults","volume":"13","author":"Bai","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"10.1016\/j.seizure.2021.07.019_bib0017","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1528-1167.2007.01402.x","article-title":"Weight issues for people with epilepsy\u2013a review","volume":"48","author":"Ben-Menachem","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1528-1167.2009.02206.x","article-title":"The metabolic syndrome in overweight epileptic patients treated with valproic acid","volume":"51","author":"Verrotti","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.seizure.2015.02.022","article-title":"Interactions between antiepileptic drugs and hormones","volume":"28","author":"Svalheim","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2021.07.019_bib0020","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.yebeh.2011.11.024","article-title":"Low serum leptin level is associated with zonisamide-induced weight loss in overweight female epilepsy patients","volume":"23","author":"Kim","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.07.019_bib0021","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/epi.14505","article-title":"The expression of inflammatory markers and their potential influence on efflux transporters in drug-resistant mesial temporal lobe epilepsy tissue","volume":"59","author":"Weidner","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/nan.12444","article-title":"Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies","volume":"44","author":"van Vliet","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.seizure.2021.07.019_bib0023","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2021.07.019_bib0024","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","article-title":"Central nervous system control of food intake","volume":"404","author":"Schwartz","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.seizure.2021.07.019_bib0025","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits antitumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat Immunol"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121002454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:59:23Z","timestamp":1761011963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121002454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":25,"alternative-id":["S1059131121002454"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.019","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of overweight and obesity with drug-resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}